Julia Binder, Head of Fetal Medicine and Associate Professor at the Department of Obstetrics and Fetomaternal Medicine at the Medical University of Vienna, has been recognised as a finalist in the prestigious Medis Awards. Her work on the prognostic significance of angiogenic markers in pregnancies with foetal growth restriction (FGR) provides promising findings for clinical practice and is now being recognised internationally.
Foetal growth restriction is one of the most common and serious complications of pregnancy. It can significantly increase the risk of perinatal morbidity and mortality and is closely associated with pre-eclampsia - a condition characterised by high blood pressure and organ damage during pregnancy.
In her excellent study entitled "Prognostic Value of Angiogenic Markers in Pregnancy with Fetal Growth Restriction" (published in "Ultrasound in Obstetrics & Gynecology"), Julia Binder identifies new angiogenic biomarkers that can contribute to better risk assessment in FGR patients. These markers enable early differentiation between pregnancies with and without impending pre-eclampsia. This could help to avoid unnecessary medical interventions and at the same time provide targeted care for patients at risk.
"The results of our research show that angiogenic markers can be valuable predictive indicators. They enable customised care for pregnant women with fetal growth restriction and could influence clinical guidelines in the long term," explains Julia Binder.
Julia Binder is an expert in the field of fetomaternal medicine. Following her specialist training, she completed fellowships in fetal medicine at St George’s Hospital in London and in foetomaternal medicine at MedUni Vienna. She completed her habilitation in 2021 with a thesis on angiogenic markers and maternal haemodynamics in hypertensive pregnancy disorders. She also heads the pre-eclampsia research group at the Medical University of Vienna.
Julia Binder’s latest findings open up new perspectives in prenatal medicine and provide a basis for further research. Her work contributes to improving the care of pregnant women with FGR and recognising potential risks at an early stage.
The International Medis Awards for Medical Research is an annual international competition for physicians and pharmacists who have published medical research findings in a specific medical field in a high-ranking scientific publication and are actively involved on a daily basis in clinical practice in institutions throughout the region. The award ceremonies take place in a different host country each year. The submitted scientific research papers are evaluated by an independent international scientific committee.
